Cargando…

Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China

IMPORTANCE: The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) threatens global public health. The association between clinical characteristics of the virus and neutralizing antibodies (NAbs) against this virus have not been well s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Fan, Liu, Mei, Wang, Aojie, Lu, Lu, Wang, Qimin, Gu, Chenjian, Chen, Jun, Wu, Yang, Xia, Shuai, Ling, Yun, Zhang, Yuling, Xun, Jingna, Zhang, Rong, Xie, Youhua, Jiang, Shibo, Zhu, Tongyu, Lu, Hongzhou, Wen, Yumei, Huang, Jinghe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377417/ https://www.ncbi.nlm.nih.gov/pubmed/32808970 http://dx.doi.org/10.1001/jamainternmed.2020.4616

Ejemplares similares

Novel sarbecovirus bispecific neutralizing antibodies with exceptional breadth and potency against currently circulating SARS-CoV-2 variants and sarbecoviruses
por: Wang, Yingdan, et al.
Publicado: (2022)

RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
por: Liu, Zezhong, et al.
Publicado: (2020)

Editing out HIV: application of gene editing technology to achieve functional cure
por: Xun, Jingna, et al.
Publicado: (2021)

Pandemic (H1N1) 2009, Shanghai, China
por: Shen, Yinzhong, et al.
Publicado: (2010)

Clinical progression of patients with COVID-19 in Shanghai, China
por: Chen, Jun, et al.
Publicado: (2020)

Identification of Human Single-Domain Antibodies against SARS-CoV-2
por: Wu, Yanling, et al.
Publicado: (2020)

Griffithsin with A Broad-Spectrum Antiviral Activity by Binding Glycans in Viral Glycoprotein Exhibits Strong Synergistic Effect in Combination with A Pan-Coronavirus Fusion Inhibitor Targeting SARS-CoV-2 Spike S2 Subunit
por: Cai, Yanxing, et al.
Publicado: (2020)

Epidemiology and clinical course of COVID-19 in Shanghai, China
por: Shen, Yinzhong, et al.
Publicado: (2020)

An analysis of drug resistance among people living with HIV/AIDS in Shanghai, China
por: Zhang, Fengdi, et al.
Publicado: (2017)

Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants
por: Yi, Chunyan, et al.
Publicado: (2021)

Analysis of liver injury factors in 332 patients with COVID-19 in Shanghai, China
por: Guo, Hongying, et al.
Publicado: (2020)

Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD
por: Zhou, Yunjiao, et al.
Publicado: (2021)

Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China
por: Wang, Zhenyan, et al.
Publicado: (2019)

Spectrum of Opportunistic Infections and Risk Factors for In-Hospital Mortality of Admitted AIDS Patients in Shanghai
por: Luo, Bin, et al.
Publicado: (2016)

Prevalence and clinical management of cytomegalovirus retinitis in AIDS patients in shanghai, china
por: Shi, Ying, et al.
Publicado: (2011)

Neutralization of five SARS-CoV-2 variants of concern by convalescent and BBIBP-CorV vaccinee serum
por: Zhu, Yuqi, et al.
Publicado: (2022)

A pan-sarbecovirus vaccine based on RBD of SARS-CoV-2 original strain elicits potent neutralizing antibodies against XBB in non-human primates
por: Liu, Zezhong, et al.
Publicado: (2023)

A broadly neutralizing antibody against SARS-CoV-2 Omicron variant infection exhibiting a novel trimer dimer conformation in spike protein binding
por: Wang, Yingdan, et al.
Publicado: (2022)

Prognosis of 18 H7N9 Avian Influenza Patients in Shanghai
por: Lu, Shuihua, et al.
Publicado: (2014)

Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines
por: Rao, Lang, et al.
Publicado: (2020)

Self-Assembly M2e-Based Peptide Nanovaccine Confers Broad Protection Against Influenza Viruses
por: Wang, Qimin, et al.
Publicado: (2020)

Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies
por: Wang, Yingdan, et al.
Publicado: (2022)

The neutralization of B.1.617.1 and B.1.1.529 sera from convalescent patients and BBIBP-CorV vaccines
por: Yang, Xinyi, et al.
Publicado: (2022)

Inefficiency of Sera from Mice Treated with Pseudotyped SARS-CoV to Neutralize 2019-nCoV Infection
por: Liu, Zezhong, et al.
Publicado: (2020)

Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV
por: Jiang, Wen, et al.
Publicado: (2021)

Rapid decline of neutralizing antibodies is associated with decay of IgM in adults recovered from mild COVID-19
por: Harrington, Whitney E., et al.
Publicado: (2021)

Efficacy of comprehensive cognitive health management for Shanghai community older adults with mild cognitive impairment
por: Qiu, Jiayuan, et al.
Publicado: (2022)

Observations about symptomatic and asymptomatic infections of 494 patients with COVID-19 in Shanghai, China
por: Mei, Xue, et al.
Publicado: (2020)

Altered Gut Microbiota and Its Clinical Relevance in Mild Cognitive Impairment and Alzheimer’s Disease: Shanghai Aging Study and Shanghai Memory Study
por: Zhu, Zheng, et al.
Publicado: (2022)

Discovery of Potential Plasma Biomarkers for Tuberculosis in HIV-Infected Patients by Data-Independent Acquisition-Based Quantitative Proteomics
por: Shen, Yinzhong, et al.
Publicado: (2020)

Epidemiology and Genetic Characterization of Classical Human Astrovirus Infection in Shanghai, 2015–2016
por: Wu, Limeng, et al.
Publicado: (2020)

Mild infection of a novel H7N9 avian influenza virus in children in Shanghai
por: Yu, Xuelian, et al.
Publicado: (2013)

Challenges in detecting and managing mild cognitive impairment in primary care: a focus group study in Shanghai, China
por: Lu, Yuan, et al.
Publicado: (2022)

Incidence and Mortality of Sarcomas in Shanghai, China, During 2002–2014
por: Pingping, Bao, et al.
Publicado: (2019)

Unmet needs of symptom management and associated factors among the HIV-positive population in Shanghai, China: A cross-sectional study
por: Dong, Ning, et al.
Publicado: (2020)

Decline in neutralising antibody responses, but sustained T‐cell immunity, in COVID‐19 patients at 7 months post‐infection
por: Chen, Jun, et al.
Publicado: (2021)

EK-16A liposomes enhance HIV replication in ACH2 or J-Lat 10.6 cell engrafted NSG mice
por: Lu, Panpan, et al.
Publicado: (2022)

An ultrapotent pan-β-coronavirus lineage B (β-CoV-B) neutralizing antibody locks the receptor-binding domain in closed conformation by targeting its conserved epitope
por: Liu, Zezhong, et al.
Publicado: (2021)

Impact of the COVID‐19 pandemic on acute stroke care: An analysis of the 24‐month data from a comprehensive stroke center in Shanghai, China
por: Hu, Qimin, et al.
Publicado: (2023)

Retraction Note to: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion
por: Wang, Xinling, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lctcrbsgnf7njdliplmsi5racu